
Loading, please wait...

Loading, please wait...

This randomised clinical trial evaluated the use of a mobile patient lift to support early mobilisation of mechanically ventilated ICU patients. The intervention addresses a common implementation barrier: patients may be clinically eligible for movement but difficult or unsafe to mobilise manually because of lines, devices, weakness and body habitus. The value of the study lies in linking a practical piece of equipment with a broader ICU liberation strategy. Early mobility is not only about motivation; it also depends on staffing, training, space, equipment and risk management. Technology that reduces the physical burden on staff may help more patients reach meaningful mobility milestones. For HCPs, the key lesson is that mobilisation programmes should be designed around workflow. A lift can complement, but does not replace, multidisciplinary assessment, clear criteria for stopping activity and progressive rehabilitation goals. The intervention is especially relevant to units trying to move from “mobilisation when convenient” toward a routine daily practice. The paper fits CritiCARE 2026's emphasis on physiotherapy, early mobilisation, humanised care and recovery after critical illness. It also reinforces a broader quality-improvement principle: when evidence-based care is not consistently delivered, practical system redesign can be as important as clinical knowledge.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This randomised clinical trial evaluated the use of a mobile patient lift to support early mobilisation of mechanically ventilated ICU patients. The intervention addresses a common implementation barrier: patients may be clinically eligible for movement but difficult or unsafe to mobilise manually because of lines, devices, weakness and body habitus. The value of the study lies in linking a practical piece of equipment with a broader ICU liberation strategy. Early mobility is not only about motivation; it also depends on staffing, training, space, equipment and risk management. Technology that reduces the physical burden on staff may help more patients reach meaningful mobility milestones. For HCPs, the key lesson is that mobilisation programmes should be designed around workflow. A lift can complement, but does not replace, multidisciplinary assessment, clear criteria for stopping activity and progressive rehabilitation goals. The intervention is especially relevant to units trying to move from “mobilisation when convenient” toward a routine daily practice. The paper fits CritiCARE 2026's emphasis on physiotherapy, early mobilisation, humanised care and recovery after critical illness. It also reinforces a broader quality-improvement principle: when evidence-based care is not consistently delivered, practical system redesign can be as important as clinical knowledge.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back